All News
|
Research Feature
The human genome was fully sequenced more than 20 years ago and is powering ways to predict, treat, and prevent cardiovascular disease As researchers study the genetic underpinnings of heart and vascular disease, they are creating new ways to screen, diagnose, and treat patients for a variety of heart conditions. Some are exploring how to better...
Showing 10 out of 271 results
|
News Release
In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard...
|
Media Advisory
WHAT: Scientists from across the nation will gather June 3-4 to discuss what is known about sickle cell trait and the potential health implications related to this genetic blood condition. "Framing the Research Agenda for Sickle Cell Trait" will examine the ethical, legal, social, and public health impacts of the blood condition. The two-day...
|
News Release
Infants born with a severely underdeveloped heart who undergo a newer surgical procedure are more likely to survive their first year and not require a heart transplant than those who have a more traditional surgical procedure, according to a report by researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), which is part of...
|
News Release
The National Institutes of Health announced today the awarding of 10 new Centers for Population Health and Health Disparities, designed to better understand and address inequities associated with the two leading causes of death in the United States – cancer and heart disease. The program is supported by the NIH's National Cancer Institute (NCI)...
|
News Release
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role. The analysis, which was supported by the National Institutes...
|
News Release
Taking vitamin C and E supplements starting in early pregnancy does not reduce the risk for the hypertensive disorders and their complications that occur during pregnancy, according to a study by a National Institutes of Health research network. The supplements notably failed to reduce the risk of preeclampsia, a potentially fatal form of...
|
News Release
Lowering blood pressure to normal levels – below currently recommended levels – did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control...
|
News Release
Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states. Led by Mark Davis...
|
News Release
Scientists have devised a new computational model that can be used to reveal genetic regulatory elements responsible for development of the human heart and maintenance of its function. Although the teams focused on the heart, the computational method they developed is broadly applicable to other tissues, and was successfully used to identify...
|
News Release
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more...